Drug Shortage Report for MYLAN-BUDESONIDE AQ
Report ID | 23169 |
Drug Identification Number | 02241003 |
Brand name | MYLAN-BUDESONIDE AQ |
Common or Proper name | BUDESONIDE AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 64MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 120 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-10-30 |
Actual start date | 2018-11-05 |
Estimated end date | 2020-03-03 |
Actual end date | 2020-03-03 |
Shortage status | Resolved |
Updated date | 2020-03-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v55 | 2018-07-25 | English | Compare |
v54 | 2018-07-05 | French | Compare |
v53 | 2018-07-05 | English | Compare |
v52 | 2018-05-23 | French | Compare |
v51 | 2018-05-23 | English | Compare |
v50 | 2018-05-11 | French | Compare |
v49 | 2018-05-11 | English | Compare |
v48 | 2018-01-30 | English | Compare |
v47 | 2018-01-29 | French | Compare |
v46 | 2018-01-29 | English | Compare |
v45 | 2018-01-22 | French | Compare |
v44 | 2018-01-22 | English | Compare |
v43 | 2018-01-08 | French | Compare |
v42 | 2018-01-08 | English | Compare |
v41 | 2017-12-20 | French | Compare |
v40 | 2017-12-20 | English | Compare |
v39 | 2017-12-14 | French | Compare |
v38 | 2017-12-14 | English | Compare |
v37 | 2017-12-14 | English | Compare |
v36 | 2017-12-13 | French | Compare |